Frustrated medication – Mail.ru News

Disturbances in public purchases of essential medicines have become widespread. During the first half of 2019, the number of failed tender calls doubled to reach 60,800. The main reason was the Department of Health's new methodology for setting the maximum price of $ 40,000. a public contract. The department therefore tried to equalize the purchase prices throughout the country, but the mechanism was disadvantageous for the manufacturers who mbadively refused to participate in the bids.

According to the results of the first half of 2019, the number of drug purchases failed by the state almost doubled compared to the same period last year, rising from 31,800 to 60,800 .

This accounts for more than a quarter of calls for tenders launched in the first half of 2019. They were recognized for 163,400. The badysis company Headway has prepared the corresponding calculations for Kommersant. As a result, the total volume of disturbed auctions increased by 52% from 26 billion rubles. up to 39.7 billion rubles. Most offers – 55 600 – did not take place because of lack of applications. Another 2.8 thousand were canceled as a result of the refusal to place an order and 2.1 thousand did not take place because of prohibit all participants.

Many companies avoid participating in public procurement because of Initial price contract (NMCC) too low set by the client of the State, DSM Group General Manager, Sergey Shulyak, is certain Since January 2019, in accordance with the ordinance of the Ministry of Health No. 871n, state customers began using the calculation model at reference prices when they justified the NMCC for the supply of drugs. According to this document, the state client must set the cost of the contract as low as possible. The failed auctions must be announced again with a slight price increase, which takes at least a month, says Shulyak.

A new methodology has been adopted to equalize public procurement prices in different regions, as the cost of the same drugs may vary significantly.

Ivan Glushkov

Deputy Director General Stada CIS

At the same time, for example, when calculating NMCC for relatively low deliveries, the prices of large offers are taken into account, he continues. Mr Glushkov recalled that the Ministry of Health published explanations during the first quarter, following which the prices calculated according to the methodology are "indicative". Moreover, if the subject wants to indicate a higher NMCC, he will have to justify such a decision, and the regions do not want to take their responsibilities, says top manager.

According to Headway, the vast majority of unsuccessful offers are regional. In addition, the purchase of inexpensive drugs, such as sodium chloride (4.7 000 unsuccessful bids), dextrose (3200), prednisone (2400), was disrupted. According to Sergey Shulyak, besides the low cost, the state customer also indicates a too small volume of supply, which is disadvantageous for companies.

Of the federal tender calls (21 did not take place), bids for the delivery of a drug for the treatment of lamivudine against HIV have failed most often, according to Headway.

This medicine is one of the main drugs bought for Infected with HIV and is included in almost all treatment regimens. Since the beginning of the year, the Ministry of Health has announced three auctions for its supplies: five in February. Only two contracts were concluded with R-Pharm JSC and the UK company GlaxoSmithKline, three in May, where there was only one supplier (Kosmofarm LLC). two in June. The last time the department could conclude that only one contract with Alvis LLC.

After the failure of the first auctions, the patient control organization has turned to 11 companies producing lamivudine to ask them to explain the reasons for their non-participation and to indicate when it was planned to provide drugs for repeated auctions. At Canonfarm and Nanolek, the non-participation in the auction was also explained by the low price of the contract.

In July, patient control activists turned to to the Prime Minister Dmitry Medvedev, calls the unprecedented situation and asks for urgent auctions, removing restrictions on participants.

The head of the monitoring department of the organization of the Coalition for Treatment Preparedness, Alexei Mikhailov, explained that, as explained by representatives of the company, unsuccessful auctions have suggested the Buying too much lamivudine, or 73.3 million tablets. According to Mr. Mikhailov, no one had such a large amount of finished product, and it is not possible to produce the drug within the timeframe, according to the manufacturers.

Now because of the current situation in several regions again It will be necessary to allocate its own funds for the independent purchase of lamivudine to ensure continuous treatment of patients.

According to him, only 14 constituent entities of the Russian Federation buy the drug themselves in 2019.

The Ministry of Health has not responded to a request from Kommersant.

Maria Kotova